News
Vesigen Therapeutics Appoints Paulash Mohsen as Chief Executive Officer
CAMBRIDGE, Mass., Apr. 11, 2022 /Business Wire/ -- Vesigen Therapeutics, Inc., a biotechnology company pioneering a novel extracellular vesicle delivery ...
Vesigen Therapeutics Presents at 3rd Exosome-Based Therapeutic Development Summit: Expanding the Therapeutic Boundaries of Exosomes
Vesigen Therapeutics, Inc., a biotechnology company pioneering a novel extracellular vesicle non-viral delivery technology to develop transformative therapeutics, will be ...
Vesigen Therapeutics Presents Data on Recent Advances to its Engineered ARMMs Therapeutic Delivery Platform at ISEV 2021
Vesigen Therapeutics, Inc., a biotechnology company pioneering development of a novel extracellular vesicle-mediated delivery platform, today announced new data supporting ...
Vesigen Therapeutics Appoints Industry Veteran Dieter Weinand to Board of Directors
Vesigen Therapeutics, Inc., a biotechnology company pioneering a novel extracellular vesicle delivery technology, today announced the addition of seasoned life ...
Vesigen Therapeutics Announces Issuance of U.S. Patent for Broad Applications of ARMMs Technology
Vesigen Therapeutics Announces Issuance of U.S. Patent for Broad Applications of ARMMs Technology Vesigen Therapeutics, Inc., a biotechnology company pioneering ...
Vesigen Therapeutics Names Lucio Iannone to Board of Directors
Vesigen Therapeutics Names Lucio Iannone to Board of Directors Vesigen Therapeutics, Inc., a biotechnology company pioneering a novel extracellular vesicle ...
Stay Connected
Vesigen Therapeutics
790 Memorial Drive
Suite 103
Cambridge, MA 02139
